Paper33333744
Recent Advances in the Development of Protein- and Peptide-Based Subunit Vaccines against Tuberculosis.
Bellini C and 1 other. Cells, 2020. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. Recent Advances in the Development of Protein- and Peptide-Based Subunit Vaccines against Tuberculosis. Papers, record 33333744. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33333744
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recent Advances in the Development of Protein- and Peptide-Based Subunit Vaccines against Tuberculosis.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Peptides | Major topic |
| Proteins | Major topic |
| Tuberculosis | Major topic |
| Tuberculosis Vaccines | Major topic |
| Vaccines, Subunit | Major topic |
| Amino Acid Sequence | |
| Humans |
Source PubMed
References96
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31266253 | Recent Advances in the Development of Peptide Vaccines and Their Delivery Systems Against Group A Streptococcus. | Vaccines (Basel) | 2019 | https://conductscience.org/library/papers/31266253 | PubMed |
| 2 | 23410889 | Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG. | Tuberculosis (Edinb) | 2013 | https://conductscience.org/library/papers/23410889 | PubMed |
| 3 | 32174919 | Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology. | Front Immunol | 2020 | https://conductscience.org/library/papers/32174919 | PubMed |
| 4 | 32082273 | Clinical Development of New TB Vaccines: Recent Advances and Next Steps. | Front Microbiol | 2019 | https://conductscience.org/library/papers/32082273 | PubMed |
| 5 | 29920369 | Scrutinizing Mycobacterium tuberculosis membrane and secretory proteins to formulate multiepitope subunit vaccine against pulmonary tuberculosis by utilizing immunoinformatic approaches. | Int J Biol Macromol | 2018 | https://conductscience.org/library/papers/29920369 | PubMed |
| 6 | 23391465 | Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. | Lancet | 2013 | https://conductscience.org/library/papers/23391465 | PubMed |
| 7 | 25288770 | Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/25288770 | PubMed |
| 8 | 27448625 | Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines. | Hum Vaccin Immunother | 2016 | https://conductscience.org/library/papers/27448625 | PubMed |
| 9 | 29567319 | In silico design of Mycobacterium tuberculosis epitope ensemble vaccines. | Mol Immunol | 2018 | https://conductscience.org/library/papers/29567319 | PubMed |
| 10 | 31849981 | CD4+ T Responses Other Than Th1 Type Are Preferentially Induced by Latency-Associated Antigens in the State of Latent Mycobacterium tuberculosis Infection. | Front Immunol | 2019 | https://conductscience.org/library/papers/31849981 | PubMed |
| 11 | 32437659 | Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection. | Cell | 2020 | https://conductscience.org/library/papers/32437659 | PubMed |
| 12 | 31064713 | Enhanced delivery of Mycobacterium tuberculosis antigens to antigen presenting cells using RVG peptide. | Tuberculosis (Edinb) | 2019 | https://conductscience.org/library/papers/31064713 | PubMed |
| 13 | 29545464 | Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients. | Clin Cancer Res | 2018 | https://conductscience.org/library/papers/29545464 | PubMed |
| 14 | 15126436 | Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: A 60-year follow-up study. | JAMA | 2004 | https://conductscience.org/library/papers/15126436 | PubMed |
| 15 | 29051764 | Polyfunctional CD4+ T Cells As Targets for Tuberculosis Vaccination. | Front Immunol | 2017 | https://conductscience.org/library/papers/29051764 | PubMed |
| 16 | 24717628 | Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis. | Lancet Respir Med | 2014 | https://conductscience.org/library/papers/24717628 | PubMed |
| 17 | 10919651 | Prevention of mammary tumors with a chimeric HER-2 B-cell epitope peptide vaccine. | Cancer Res | 2000 | https://conductscience.org/library/papers/10919651 | PubMed |
| 18 | 32359402 | Considering BCG vaccination to reduce the impact of COVID-19. | Lancet | 2020 | https://conductscience.org/library/papers/32359402 | PubMed |
| 19 | 23103299 | A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice. | Vaccine | 2012 | https://conductscience.org/library/papers/23103299 | PubMed |
| 20 | 10898510 | Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. | Eur J Immunol | 2000 | https://conductscience.org/library/papers/10898510 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41889758 | Chemical Strategy and AI-Enabled Peptide Vaccine Development. | JACS Au | 2026 | https://conductscience.org/library/papers/41889758 | PubMed |
| 40959074 | Tuberculosis in patients with systemic lupus erythematosus. | Front Immunol | 2025 | https://conductscience.org/library/papers/40959074 | PubMed |
| 40038239 | Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40038239 | PubMed |
| 39841361 | Tuberculosis vaccines and therapeutic drug: challenges and future directions. | Mol Biomed | 2025 | https://conductscience.org/library/papers/39841361 | PubMed |
| 39340027 | Immunogenicity and Protective Efficacy of a Multi-Antigen Mycobacterium tuberculosis Subunit Vaccine in Mice. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/39340027 | PubMed |
| 39323805 | In silico design of Mycobacterium tuberculosis multi-epitope adhesin protein vaccines. | Heliyon | 2024 | https://conductscience.org/library/papers/39323805 | PubMed |
| 38459038 | BCG-booster vaccination with HSP90-ESAT-6-HspX-RipA multivalent subunit vaccine confers durable protection against hypervirulent Mtb in mice. | NPJ Vaccines | 2024 | https://conductscience.org/library/papers/38459038 | PubMed |
| 38022657 | Recent advance in the development of tuberculosis vaccines in clinical trials and virus-like particle-based vaccine candidates. | Front Immunol | 2023 | https://conductscience.org/library/papers/38022657 | PubMed |
| 37626082 | An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosis. | NPJ Vaccines | 2023 | https://conductscience.org/library/papers/37626082 | PubMed |
| 37606258 | Design and Characterization of a Multistage Peptide-Based Vaccine Platform to Target Mycobacterium tuberculosis Infection. | Bioconjug Chem | 2023 | https://conductscience.org/library/papers/37606258 | PubMed |
| 37371548 | ESAT-6 a Major Virulence Factor of Mycobacterium tuberculosis. | Biomolecules | 2023 | https://conductscience.org/library/papers/37371548 | PubMed |
| 36992193 | A Multistage Antigen Complex Epera013 Promotes Efficient and Comprehensive Immune Responses in BALB/c Mice. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/36992193 | PubMed |
| 36839774 | Peptide Vaccines in Melanoma: Chemical Approaches towards Improved Immunotherapeutic Efficacy. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/36839774 | PubMed |
| 36672252 | A Structural View at Vaccine Development against M. tuberculosis. | Cells | 2023 | https://conductscience.org/library/papers/36672252 | PubMed |
| 36551264 | Proteome Profile Changes Induced by Heterologous Overexpression of Mycobacterium tuberculosis-Derived Antigens PstS-1 (Rv0934) and Ag85B (Rv1886c) in Mycobacterium microti. | Biomolecules | 2022 | https://conductscience.org/library/papers/36551264 | PubMed |
| 36497063 | Molecular Immunology in Bacterial Vaccine Discovery. | Cells | 2022 | https://conductscience.org/library/papers/36497063 | PubMed |
| 36159845 | Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity. | Front Immunol | 2022 | https://conductscience.org/library/papers/36159845 | PubMed |
| 35173740 | Peptide-Based Vaccines for Tuberculosis. | Front Immunol | 2022 | https://conductscience.org/library/papers/35173740 | PubMed |
| 34069535 | Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34069535 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
| TLR9 | 54106 | PubTator's text mining | https://conductscience.org/library/genes/54106 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33333744
GET https://conductscience.org/api/papers/v1/33333744/references?page=2